June 30, 2022
Takeda CEO Christophe Weber Takeda Pharmaceutical CEO Christophe Weber shrugged off shareholders’ concerns over its 4-trillion-yen outstanding debt at an annual general meeting on June 29, expressing his confidence for pursuing rapid deleveraging, pipeline enhancement, and dividend payments all at...read more